The term sheet is non-binding, subject to the execution of a definitive agreement Vancouver, Canada, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0...
FDA approval for the IND submission to conduct its trial already secured Vancouver, Canada, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.13 | -9.77443609023 | 1.33 | 1.53 | 1.15 | 111891 | 1.39959141 | CS |
4 | -0.12 | -9.09090909091 | 1.32 | 1.53 | 1.15 | 63158 | 1.36427155 | CS |
12 | -0.01 | -0.826446280992 | 1.21 | 1.81 | 1.15 | 273173 | 1.47939144 | CS |
26 | 0.07 | 6.19469026549 | 1.13 | 2.3 | 1.06 | 1078107 | 1.58470478 | CS |
52 | -1.53 | -56.043956044 | 2.73 | 3.58 | 0.9205 | 1202910 | 1.77001805 | CS |
156 | -161.4 | -99.2619926199 | 162.6 | 183 | 0.9205 | 1197572 | 8.8911716 | CS |
260 | -161.4 | -99.2619926199 | 162.6 | 183 | 0.9205 | 1197572 | 8.8911716 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales